236 related articles for article (PubMed ID: 33180672)
1. Hiding in plain sight: structure and sequence analysis reveals the importance of the antibody DE loop for antibody-antigen binding.
Kelow SP; Adolf-Bryfogle J; Dunbrack RL
MAbs; 2020; 12(1):1840005. PubMed ID: 33180672
[TBL] [Abstract][Full Text] [Related]
2. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
[TBL] [Abstract][Full Text] [Related]
3. Germlining of the HIV-1 broadly neutralizing antibody domain m36.
Chen W; Li W; Ying T; Wang Y; Feng Y; Dimitrov DS
Antiviral Res; 2015 Apr; 116():62-6. PubMed ID: 25676867
[TBL] [Abstract][Full Text] [Related]
4. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.
Cale EM; Gorman J; Radakovich NA; Crooks ET; Osawa K; Tong T; Li J; Nagarajan R; Ozorowski G; Ambrozak DR; Asokan M; Bailer RT; Bennici AK; Chen X; Doria-Rose NA; Druz A; Feng Y; Joyce MG; Louder MK; O'Dell S; Oliver C; Pancera M; Connors M; Hope TJ; Kepler TB; Wyatt RT; Ward AB; Georgiev IS; Kwong PD; Mascola JR; Binley JM
Immunity; 2017 May; 46(5):777-791.e10. PubMed ID: 28514685
[TBL] [Abstract][Full Text] [Related]
5. A new clustering of antibody CDR loop conformations.
North B; Lehmann A; Dunbrack RL
J Mol Biol; 2011 Feb; 406(2):228-56. PubMed ID: 21035459
[TBL] [Abstract][Full Text] [Related]
6. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
Barrios Y; Jirholt P; Ohlin M
J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120.
Bagley J; Dillon PJ; Rosen C; Robinson J; Sodroski J; Marasco WA
Mol Immunol; 1994 Oct; 31(15):1149-60. PubMed ID: 7935503
[TBL] [Abstract][Full Text] [Related]
8. Comparative Analysis of the CDR Loops of Antigen Receptors.
Wong WK; Leem J; Deane CM
Front Immunol; 2019; 10():2454. PubMed ID: 31681328
[TBL] [Abstract][Full Text] [Related]
9. Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.
Zwick MB; Parren PW; Saphire EO; Church S; Wang M; Scott JK; Dawson PE; Wilson IA; Burton DR
J Virol; 2003 May; 77(10):5863-76. PubMed ID: 12719580
[TBL] [Abstract][Full Text] [Related]
10. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
[TBL] [Abstract][Full Text] [Related]
11. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
[TBL] [Abstract][Full Text] [Related]
12. A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.
Steichen JM; Lin YC; Havenar-Daughton C; Pecetta S; Ozorowski G; Willis JR; Toy L; Sok D; Liguori A; Kratochvil S; Torres JL; Kalyuzhniy O; Melzi E; Kulp DW; Raemisch S; Hu X; Bernard SM; Georgeson E; Phelps N; Adachi Y; Kubitz M; Landais E; Umotoy J; Robinson A; Briney B; Wilson IA; Burton DR; Ward AB; Crotty S; Batista FD; Schief WR
Science; 2019 Dec; 366(6470):. PubMed ID: 31672916
[TBL] [Abstract][Full Text] [Related]
13. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
[TBL] [Abstract][Full Text] [Related]
14. The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.
Tsuchiya Y; Mizuguchi K
Protein Sci; 2016 Apr; 25(4):815-25. PubMed ID: 26749247
[TBL] [Abstract][Full Text] [Related]
15. Length-independent structural similarities enrich the antibody CDR canonical class model.
Nowak J; Baker T; Georges G; Kelm S; Klostermann S; Shi J; Sridharan S; Deane CM
MAbs; 2016; 8(4):751-60. PubMed ID: 26963563
[TBL] [Abstract][Full Text] [Related]
16. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
[TBL] [Abstract][Full Text] [Related]
17. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
[TBL] [Abstract][Full Text] [Related]
18. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
19. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
LaBranche CC; Henderson R; Hsu A; Behrens S; Chen X; Zhou T; Wiehe K; Saunders KO; Alam SM; Bonsignori M; Borgnia MJ; Sattentau QJ; Eaton A; Greene K; Gao H; Liao HX; Williams WB; Peacock J; Tang H; Perez LG; Edwards RJ; Kepler TB; Korber BT; Kwong PD; Mascola JR; Acharya P; Haynes BF; Montefiori DC
PLoS Pathog; 2019 Sep; 15(9):e1008026. PubMed ID: 31527908
[TBL] [Abstract][Full Text] [Related]
20. Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization.
Willis JR; Finn JA; Briney B; Sapparapu G; Singh V; King H; LaBranche CC; Montefiori DC; Meiler J; Crowe JE
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4446-51. PubMed ID: 27044078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]